{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:12:29Z","timestamp":1782781949320,"version":"3.54.5"},"reference-count":25,"publisher":"Texas Heart Institute Journal","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:p>Antiplatelet therapy reduces the risk of myocardial infarction, stroke, and vascular death in patients who have symptomatic peripheral artery disease. However, a subset of patients who take aspirin continues to have recurrent cardiovascular events. There are few data on cardiovascular outcomes in patients with peripheral artery disease who manifest aspirin resistance.<\/jats:p>\n        <jats:p>Patients with peripheral artery disease on long-term aspirin therapy (\u22654 wk) were tested for aspirin responsiveness by means of the VerifyNow Aspirin Assay. The mean follow-up duration was 22.6 \u00b1 8.3 months. The primary endpoint was a composite of death, myocardial infarction, or ischemic stroke. Secondary endpoints were the incidence of vascular interventions (surgical or percutaneous), or of amputation or gangrene caused by vascular disease.<\/jats:p>\n        <jats:p>Of the 120 patients enrolled in the study, 31 (25.8%) were aspirin-resistant and 89 (74.2%) were aspirin-responsive. The primary endpoint occurred in 10 (32.3%) patients in the aspirin-resistant group and in 13 (14.6%) patients in the aspirin-responsive group (hazard ratio=2.48; 95% confidence interval, 1.08\u20135.66; <jats:italic>P<\/jats:italic>=0.03). There was no significant difference in the secondary outcome of revascularization or tissue loss. By multivariate analysis, aspirin resistance and history of chronic kidney disease were the only independent predictors of long-term adverse cardiovascular events.<\/jats:p>\n        <jats:p>Aspirin resistance is highly prevalent in patients with symptomatic peripheral artery disease and is an independent predictor of adverse cardiovascular risk. Whether intervening in these patients with additional antiplatelet therapies would improve outcomes needs to be explored.<\/jats:p>","DOI":"10.14503\/thij-14-4986","type":"journal-article","created":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T23:13:42Z","timestamp":1481930022000},"page":"482-487","source":"Crossref","is-referenced-by-count":19,"title":["Aspirin Resistance Predicts Adverse Cardiovascular Events in Patients with Symptomatic Peripheral Artery Disease"],"prefix":"10.14503","volume":"43","author":[{"given":"Tilak","family":"Pasala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Soo","family":"Hoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Kate","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna","family":"Sengodan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5628","reference":[{"issue":"6921","key":"i1526-6702-43-6-482-b1","series-title":"BMJ","first-page":"81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration [published erratum appears in BMJ 1994;308(6943):1540]","volume":"308","year":"1994","unstructured":"Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration [published erratum appears in BMJ 1994;308(6943):1540]. BMJ1994;308(6921):81\u2013106."},{"issue":"7329","key":"i1526-6702-43-6-482-b2","series-title":"BMJ","first-page":"71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients [published erratum appears in BMJ 2002;324(7330):141]","volume":"324","year":"2002","unstructured":"Antithrombotic Trialists' Collaboration. \n          Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients [published erratum appears in BMJ 2002;324(7330):141]. BMJ2002;324(7329):71\u201386."},{"issue":"14","key":"i1526-6702-43-6-482-b3","series-title":"Circulation","first-page":"1650","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","year":"2002","unstructured":"Eikelboom\n              JW\n            , HirshJ, WeitzJI, JohnstonM, YiQ, YusufS.\n          Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation2002;105(14):1650\u20135."},{"issue":"9510","key":"i1526-6702-43-6-482-b4","series-title":"Lancet","first-page":"606","article-title":"Aspirin resistance","volume":"367","year":"2006","unstructured":"Hankey\n              GJ\n            , EikelboomJW.\n          Aspirin resistance. Lancet2006;367(9510):606\u201317."},{"issue":"11","key":"i1526-6702-43-6-482-b5","series-title":"Clin Cardiol","first-page":"673","article-title":"Aspirin resistance: current status and role of tailored therapy","volume":"35","year":"2012","unstructured":"Grinstein\n              J\n            , CannonCP.\n          Aspirin resistance: current status and role of tailored therapy. Clin Cardiol2012;35(11):673\u201381."},{"issue":"7","key":"i1526-6702-43-6-482-b6","series-title":"Am J Med","first-page":"631","article-title":"Aspirin resistance and adverse clinical events in patients with coronary artery disease","volume":"120","year":"2007","unstructured":"Chen\n              WH\n            , ChengX, LeePY, NgW, KwokJY, TseHF, LauCP.\n          Aspirin resistance and adverse clinical events in patients with coronary artery disease. Am J Med2007;120(7):631\u20135."},{"issue":"21","key":"i1526-6702-43-6-482-b7","series-title":"J Am Coll Cardiol","first-page":"1736","article-title":"Progression of peripheral artery disease predicts cardiovascular disease morbidity and mortality","volume":"52","year":"2008","unstructured":"Criqui\n              MH\n            , NinomiyaJK, WingardDL, JiM, FronekA.\n          Progression of peripheral artery disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol2008;52(21):1736\u201342."},{"issue":"9038","key":"i1526-6702-43-6-482-b8","series-title":"Lancet","first-page":"1329","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","unstructured":"CAPRIE Steering Committee. \n          A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet1996;348(9038):1329\u201339."},{"issue":"3","key":"i1526-6702-43-6-482-b9","series-title":"Thromb Haemost","first-page":"1003","article-title":"Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty","volume":"78","year":"1997","unstructured":"Mueller\n              MR\n            , SalatA, StanglP, MurabitoM, PulakiS, BoehmD, \n          et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost1997;78(3):1003\u20137."},{"issue":"6","key":"i1526-6702-43-6-482-b10","series-title":"Thromb Haemost","first-page":"1245","article-title":"A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease","volume":"103","year":"2010","unstructured":"Grove\n              EL\n            , HvasAM, JohnsenHL, HedegaardSS, PedersenSB, MortensenJ, KristensenSD.\n          A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease. Thromb Haemost2010;103(6):1245\u201353."},{"issue":"2","key":"i1526-6702-43-6-482-b11","series-title":"J Biomed Inform","first-page":"377","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","year":"2009","unstructured":"Harris\n              PA\n            , TaylorR, ThielkeR, PayneJ, GonzalezN, CondeJG.\n          Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform2009;42(2):377\u201381."},{"issue":"6","key":"i1526-6702-43-6-482-b12","series-title":"J Am Coll Cardiol","first-page":"961","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease [published erratum appears in J Am Coll Cardiol 2006;48(9):1918]","volume":"41","year":"2003","unstructured":"Gum\n              PA\n            , Kottke-MarchantK, WelshPA, WhiteJ, TopolEJ.\n          A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease [published erratum appears in J Am Coll Cardiol 2006;48(9):1918]. J Am Coll Cardiol2003;41(6):961\u20135."},{"issue":"5","key":"i1526-6702-43-6-482-b13","series-title":"Thromb Res","first-page":"397","article-title":"Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients","volume":"71","year":"1993","unstructured":"Grotemeyer\n              KH\n            , ScharafinskiHW, HusstedtIW.\n          Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res1993;71(5):397\u2013403."},{"issue":"1","key":"i1526-6702-43-6-482-b14","series-title":"Thromb Res","first-page":"37","article-title":"Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease","volume":"108","year":"2002","unstructured":"Andersen\n              K\n            , HurlenM, ArnesenH, SeljeflotI.\n          Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease. Thromb Res2002;108(1):37\u201342."},{"issue":"1","key":"i1526-6702-43-6-482-b15","series-title":"Tohoku J Exp Med","first-page":"59","article-title":"High frequency of aspirin resistance in patients with acute coronary syndrome","volume":"207","year":"2005","unstructured":"Hobikoglu\n              GF\n            , NorgazT, AksuH, OzerO, ErturkM, NurkalemZ, NarinA.\n          High frequency of aspirin resistance in patients with acute coronary syndrome. Tohoku J Exp Med2005;207(1):59\u201364."},{"issue":"6","key":"i1526-6702-43-6-482-b16","series-title":"J Am Coll Cardiol","first-page":"1122","article-title":"Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment","volume":"43","year":"2004","unstructured":"Chen\n              WH\n            , LeePY, NgW, TseHF, LauCP.\n          Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol2004;43(6):1122\u20136."},{"issue":"4","key":"i1526-6702-43-6-482-b17","series-title":"Int Urol Nephrol","first-page":"1097","article-title":"Follow-up of aspirin-resistant patients with end-stage kidney disease","volume":"45","year":"2013","unstructured":"Kilickesmez\n              KO\n            , KocasC, AbaciO, OkcunB, GorcinB, GurmenT.\n          Follow-up of aspirin-resistant patients with end-stage kidney disease. Int Urol Nephrol2013;45(4):1097\u2013102."},{"issue":"7637","key":"i1526-6702-43-6-482-b18","series-title":"BMJ","first-page":"195","article-title":"Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta-analysis","volume":"336","year":"2008","unstructured":"Krasopoulos\n              G\n            , BristerSJ, BeattieWS, BuchananMR.\n          Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ2008;336(7637):195\u20138."},{"issue":"24","key":"i1526-6702-43-6-482-b19","series-title":"J Am Coll Cardiol","first-page":"2428","article-title":"Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: The PRECLOP study: clinical impact and optimal cutoff value of on-treatment high platelet reactivity","volume":"61","year":"2013","unstructured":"Spiliopoulos\n              S\n            , PastromasG, KatsanosK, KitrouP, KarnabatidisD, SiablisD.\n          Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: The PRECLOP study: clinical impact and optimal cutoff value of on-treatment high platelet reactivity. J Am Coll Cardiol2013;61(24):2428\u201334."},{"issue":"1","key":"i1526-6702-43-6-482-b20","series-title":"J Vasc Surg","first-page":"157","article-title":"Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral artery disease","volume":"62","year":"2015","unstructured":"Armstrong\n              EJ\n            , AndersonDR, YeoKK, SinghGD, BangH, AmsterdamEA, \n          et al. Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral artery disease. J Vasc Surg2015;62(1):157\u2013165.e1."},{"issue":"5","key":"i1526-6702-43-6-482-b21","series-title":"Curr Opin Cardiol","first-page":"487","article-title":"The hazards of discontinuing acetylsalicylic acid therapy in those at risk of coronary artery disease","volume":"23","year":"2008","unstructured":"Lotrionte\n              M\n            , Biondi-ZoccaiGG.\n          The hazards of discontinuing acetylsalicylic acid therapy in those at risk of coronary artery disease. Curr Opin Cardiol2008;23(5):487\u201393."},{"issue":"9","key":"i1526-6702-43-6-482-b22","series-title":"JAMA","first-page":"841","article-title":"Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial","volume":"303","year":"2010","unstructured":"Fowkes\n              FG\n            , PriceJF, StewartMC, ButcherI, LengGC, PellAC, \n          et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA2010;303(9):841\u20138."},{"issue":"19","key":"i1526-6702-43-6-482-b23","series-title":"J Am Coll Cardiol","first-page":"2020","article-title":"2011 ACCF\/AHA Focused Update of the Guideline for the Management of Patients with Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"58","year":"2011","unstructured":"Rooke\n              TW\n            , HirschAT, MisraS, SidawyAN, BeckmanJA, FindeissLK, \n          et al. 2011 ACCF\/AHA Focused Update of the Guideline for the Management of Patients with Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol2011;58(19):2020\u201345."},{"issue":"6","key":"i1526-6702-43-6-482-b24","series-title":"J Thromb Haemost","first-page":"1309","article-title":"Aspirin resistance: position paper of the Working Group on Aspirin Resistance","volume":"3","year":"2005","unstructured":"Michelson\n              AD\n            , CattaneoM, EikelboomJW, GurbelP, Kottke-MarchantK, KunickiTJ, \n          et al. Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Haemost2005;3(6):1309\u201311."},{"issue":"6","key":"i1526-6702-43-6-482-b25","series-title":"J Am Coll Cardiol","first-page":"979","article-title":"Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients","volume":"43","year":"2004","unstructured":"Pulcinelli\n              FM\n            , PignatelliP, CelestiniA, RiondinoS, GazzanigaPP, VioliF.\n          Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients. J Am Coll Cardiol2004;43(6):979\u201384."}],"container-title":["Texas Heart Institute Journal"],"original-title":[],"link":[{"URL":"https:\/\/thij.kglmeridian.com\/view\/journals\/thij\/43\/6\/article-p482.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/thij\/article-pdf\/43\/6\/482\/1879217\/thij-14-4986.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thij.kglmeridian.com\/downloadpdf\/journals\/thij\/43\/6\/article-p482.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thij.kglmeridian.com\/downloadpdf\/journals\/thij\/43\/6\/article-p482.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T15:32:59Z","timestamp":1730993579000},"score":1,"resource":{"primary":{"URL":"https:\/\/thij.kglmeridian.com\/view\/journals\/thij\/43\/6\/article-p482.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":25,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.14503\/thij-14-4986","relation":{},"ISSN":["0730-2347","1526-6702"],"issn-type":[{"value":"0730-2347","type":"print"},{"value":"1526-6702","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}